Navigation Links
Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31, 2009
Date:9/23/2009

NANTONG CITY, China, Sept. 23 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma" or the "Company") is pleased to report financial highlights from the audited financial results for the fiscal year ended May 31, 2009.

    Financial highlights include:
    -- Sales revenue increased to US$3,850,278 for the 12 months ended May 31,
       2009, from US$1,810,318 in the corresponding period ended May 31, 2008,
       a year-over-year increase of 112.69 percent.

    -- Gross profit increased to US$2,538,441, representing 66 percent of
       sales revenue, for the 12 months ended May 31, 2009, from US$580,915,
       representing 32 percent of revenue, in the corresponding period ended
       May 31, 2008.

    -- Net profit of the Company's wholly owned operating subsidiary, Dong
       Ying (Jiangsu) Pharmaceutical Co., Ltd., increased to US$1,019,507
       representing 26% of sales revenue, for the 12 months ended May 31, 2009,
       from -US$199,306 in the corresponding period ended May 31, 2008, a
       year-over-year increase of more than 400 percent.  However, the
       Company's overall net loss increased to US$2,140,237 for the 12 months
       ended May 31, 2009, of which one of the main expenses affecting the
       results of operations was the stock-based compensation charge of
       US$2,917,125, reflecting the vesting of stock options granted by the
       Company and professional fee of public company administration (audit,
       legal, etc.) of US$270,518.

    -- Increase in sales volume and the improvement in gross profit percentage
       are both due to growth in sales of Cisatracurium Besylate, a pre-
       surgical skeletal muscle relaxant.  Sales of this product increased to
       US$3,595,031 in the 12 months ended May 31, 2009, from US$1,364,165 in
       the 12 months ended May 31, 2008.  At the same time, as volume has
       increased, cost of manufacturing Cisatra
'/>"/>
SOURCE  Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related biology technology :

1. Emissary Capital Group Initiates Coverage on Sinobiopharma
2. Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate
3. Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
4. Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug Perindopril
5. Sinobiopharma Secures Rights to Seven Key Patents
6. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
7. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
8. Sinobiopharma, Inc. Appoints New Director of Marketing
9. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
10. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
11. Economic Strength of Hawaii Seed Crop Industry Confirmed by Recent Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... SAN MARINO, Calif., Dec. 15 Epeius ... of targeted genetic medicine, gained international validation of ... Rexin-G , when scientists around the world ... be a major locus of cancer pathogenesis and ... anti-cancer therapies. Recently, scientists at the NIH National ...
(Date:12/15/2009)... HARBIN, China, Dec. 15 /PRNewswire-Asia-FirstCall/ -- China Sky ... Company") (Nasdaq: CSKI ), a,leading fully integrated ... People,s Republic of China ("PRC"), today,announced that the ... in the 2009,Edition of the National Basic Medical ... , The 30 medicines ...
(Date:12/15/2009)... WILMINGTON, Del. and CHARLOTTESVILLE, Va., Dec. 15 ... ) and the University of Virginia (UVa) ... entered into a strategic research collaboration to ... coronary artery disease (CAD) with a secondary ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The ...
(Date:12/15/2009)... N.Y., Dec. 15 The International Society ... the professional society is continuing to accept abstracts ... held in Arlington, VA, April 19-21, 2010. This ... encouraging non-members to join the organization to submit ... submission deadline is 12 AM EST, January 15, ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3
... R&D Magazine Selects Axxent(R) Miniature Brachytherapy X-ray Source as ... Products of the Past Year, SUNNYVALE, Calif., July ... Dose Rate (HDR) X-ray Source has been selected to,receive ... of the year,s most,technologically significant products. Established by the ...
... Dissection System Represents Important Advance in Radiofrequency ... Surgical Technologies -, ... device company that has developed a new tissue dissection system,based on ... has granted the company 510(k) clearance to market its,PEAK(R) Surgery System ...
... Centerpiece to Expansion of ... Radiation Oncology Facility, SUNNYVALE, ... global leader in the field of radiosurgery,today announced that St. ... System to further expand treatment,offerings for its nationally recognized NeuroScience ...
Other Biology Technology:Xoft Recognized With R&D 100 Award 2Xoft Recognized With R&D 100 Award 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 2St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 3St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 4
(Date:12/16/2009)... Scotland, Canada and the US have proposed a ... conservation. The team,s findings, published in Animal ... identified through feeding behaviour, can benefit highly mobile ... are enormous challenges associated with setting conservation priorities ... said lead author Erin Ashe, a PhD student ...
(Date:12/16/2009)... is a vital source of financial and technical assistance ... this may not appear to be connected to space ... Earth,s environment are intrinsically linked. , Global climate change ... and advancing development in the poorest countries and communities, ... These factors have led to a growing demand for ...
(Date:12/16/2009)... Signal Hill, CA Tom Bowman, an expert in ... Bowman Global Change, has developed a series of graphics ... on Climate Change (IPCC) report for public audiences. These ... information they need to make informed decisions about climate ... format as a means to clearly and accurately communicate ...
Breaking Biology News(10 mins):Zoning the ocean may help endangered whales to recover 2Zoning the ocean may help endangered whales to recover 3ESA and World Bank move toward closer collaboration 2ESA and World Bank move toward closer collaboration 3ESA and World Bank move toward closer collaboration 4Bowman creates graphic translation of climate change data 2BioLife Solutions Granted Japanese Biopreservation Patent 14896 1BioLife Solutions Granted Japanese Biopreservation Patent 14896 2BioLife Solutions Granted Japanese Biopreservation Patent 14896 3AMT Provides Business Update for the Third Quarter 2009 14895 1AMT Provides Business Update for the Third Quarter 2009 14895 2AMT Provides Business Update for the Third Quarter 2009 14895 3AMT Provides Business Update for the Third Quarter 2009 14895 4Huge Exhibition to Demonstrate Training for Irregular Warfare 14892 1Huge Exhibition to Demonstrate Training for Irregular Warfare 14892 2Huge Exhibition to Demonstrate Training for Irregular Warfare 14892 3
... Center Oakland is leading one of two teams in ... mice for a study to understand the role of ... the team represent the School of Veterinary Science at ... Sanger Institute in Hinxton, England. The National Institutes ...
... of Differentiation, guest-edited by Brigid Hogan, highlights several ... as branching morphogenesis. Through a series of seven ... animal development are revealed. The articles analyze how ... the same species. They also compare the process ...
... an important role in longevity, with longer-lived rodents showing ... metabolism, a new study has found. , The study ... metabolism, the shorter its life, and vice versa, said ... hormones that regulate metabolic rate. , "Thyroid hormones ...
Other Biology News:Knockout Mouse Project 2Longer-lived rodents have lower levels of thyroid hormone 2
Chicken Aortic Smooth Muscle Cells (CAOSMC) (>500,000 cells)...
... Pathogenic Viruses The National Collection ... well characterised, authenticated human pathogenic ... and NCPV is able to ... acids derived from them, to ...
... Varioskan is a high performance spectral ... and incubator. With the advanced SkanIt ... reliability for drug discovery assay development. ... fluorescence intensity, time-resolved fluorescence and photometric ...
Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]...
Biology Products: